| Top 50 Most Viewed Posts This Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. mightycydy: CYDY's Dr. Scott Hansen & The Gates Foundation (1937)  (16) |
| 2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1624) |
| 3. My69z: No longer thinking my "$50b" napkin is just an (985) (6) |
| 4. hoops: "As previously announced, CytoDyn is preparing a (762) (17) |
| 5. PSU77: You're right, the quest to turn "cold" tumors (693) (32) |
| 6. jeff67: This drug, even though not getting through the (660) (11) |
| 7. ScottyDoggs: Someone on Stockwits reported that Zacks is (656) (10) |
| 8. Mr3Putt: So I’ll stand by my previous position that you (645) (24) |
| 9. Ramjet: Right on Onward and upward To approval and beyond (643) (2) |
| 10. sjacobs26: Patients, shareholders, and our future partner/s (641) (14) |
| 11. misiu143: I agree with you Jeff . Treating so many diseases (621) (20) |
| 12. ScottyDoggs: The data exceeds my most optimistic expectations (614) (15) |
| 13. biloxiblues: This could explain a lot of the selling over the (613) (21) |
| 14. KenChowder: My takeaway from the PR is this, and it is no (611) (26) |
| 15. ohm20: My takeaway from the PR is this, and it is no (607) (21) |
| 16. Jake2212: Nobody is mentioning that the quotes from Jay and (602) (19) |
| 17. mountaineer: Yes, it is totally speculation (but something we (599) (8) |
| 18. grow: IMO the pooled safety data to me means there is (598) (7) |
| 19. Mr3Putt: Definitely check out this post at reddit: (592) (11) |
| 20. Katangolo: It doesn’t escape me that ESMO and this breast (584) (31) |
| 21. biloxiblues: This is probably the best question ever asked on (581) (15) |
| 22. Respert24: Let's not forget that many of these patients went (581) (21) |
| 23. misiu143: There were 3 preclinical studies done recently (580) (15) |
| 24. MidnightRider: We all speculated as to why the Dream Team all (573) (8) |
| 25. Riztheinvestor: He’s blanket deleted. I can’t take his (572) (13) |
| 26. Boatbuilder: Today will be interesting. Frequently when the (566) (8) |
| 27. My69z: Trump EO on drug pricing out: (560) (6) |
| 28. Plotinus: Beyond the PR today: inferences of note: Outside (560) (31) |
| 29. ohm20: I just saw the presentation poster. High PD-L1 (556) (35) |
| 30. ohm20: PD-L1 is a defense mechanism by the tumor. PD-L1 (556) (29) |
| 31. Riztheinvestor: It means anyone with PD-L1s will be knocking on (556) (15) |
| 32. Ganesha: Re Zack’s: Well, it couldn’t hurt! Maybe (555) (4) |
| 33. KenChowder: Forgot to add this: "CytoDyn’s results indicate (553) (26) |
| 34. biloxiblues: 3rd Resistance Point 0.4969 2nd Resistance Point (553) (4) |
| 35. Katangolo: I want to be clear Craig. I’m not your friend. (550) (19) |
| 36. biloxiblues: This ESMO 2025 poster from CytoDyn presents (549) (12) |
| 37. Katangolo: Thanks, Riz. I hope you and the other mods delete (549) (17) |
| 38. mountaineer: Big picture: It is STILL a big (542) (5) |
| 39. chazzledazzle: “ Mr. Vittner on our CRC protocol…” Is (541) (1) |
| 40. mountaineer: I do not believe they would make an announcement (536) (5) |
| 41. Crujones1985: Anyone have access from the ground in (536) (1) |
| 42. Mrkev: I am completely baffled as to how maraviroc is (535) (10) |
| 43. hoops: The fact that Cytodyn’s leadership team flew (534) (9) |
| 44. PSU77: Finally some media coverage: (533) (17) |
| 45. KenChowder: Of all the flags pointing in the right (533) (16) |
| 46. mfglola: I am completely baffled as to how maraviroc is (533) (3) |
| 47. hoops: Apparently "Oncodaily" is reporting from ESMO. I (533) (1) |
| 48. ohm20: Question: Are you satisfied with our current (532) (15) |
| 49. Buddyboy20: Does anybody remember this? "The fact that (531) (16) |
| 50. mikeyt1818: Let's hope the IR Med S-1 means they are getting (530) (7) |
